nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4A—mammary gland—lung cancer	0.00423	0.241	CbGeAlD
Roflumilast—PDE4D—lung—lung cancer	0.00169	0.0963	CbGeAlD
Roflumilast—PDE4B—respiratory system—lung cancer	0.00168	0.0957	CbGeAlD
Roflumilast—PDE4A—lung—lung cancer	0.0015	0.0852	CbGeAlD
Roflumilast—PDE4B—bronchus—lung cancer	0.00138	0.0788	CbGeAlD
Roflumilast—PDE4B—trachea—lung cancer	0.00124	0.0707	CbGeAlD
Roflumilast—PDE4B—cardiac atrium—lung cancer	0.00117	0.0664	CbGeAlD
Roflumilast—PDE4D—lymph node—lung cancer	0.00116	0.0659	CbGeAlD
Roflumilast—PDE4A—lymph node—lung cancer	0.00102	0.0583	CbGeAlD
Roflumilast—PDE4B—bone marrow—lung cancer	0.000985	0.0561	CbGeAlD
Roflumilast—PDE4B—lung—lung cancer	0.000892	0.0508	CbGeAlD
Roflumilast—Discomfort—Cisplatin—lung cancer	0.000883	0.0012	CcSEcCtD
Roflumilast—Vomiting—Vinblastine—lung cancer	0.000876	0.00119	CcSEcCtD
Roflumilast—Dizziness—Erlotinib—lung cancer	0.000875	0.00119	CcSEcCtD
Roflumilast—Ill-defined disorder—Paclitaxel—lung cancer	0.000875	0.00119	CcSEcCtD
Roflumilast—Malaise—Etoposide—lung cancer	0.000867	0.00118	CcSEcCtD
Roflumilast—Vertigo—Etoposide—lung cancer	0.000864	0.00118	CcSEcCtD
Roflumilast—Headache—Vinblastine—lung cancer	0.000863	0.00117	CcSEcCtD
Roflumilast—Angioedema—Paclitaxel—lung cancer	0.000862	0.00117	CcSEcCtD
Roflumilast—Insomnia—Irinotecan—lung cancer	0.000854	0.00116	CcSEcCtD
Roflumilast—Cardiac disorder—Docetaxel—lung cancer	0.000852	0.00116	CcSEcCtD
Roflumilast—Infection—Cisplatin—lung cancer	0.000851	0.00116	CcSEcCtD
Roflumilast—Vomiting—Topotecan—lung cancer	0.000851	0.00116	CcSEcCtD
Roflumilast—Malaise—Paclitaxel—lung cancer	0.000851	0.00116	CcSEcCtD
Roflumilast—Vertigo—Paclitaxel—lung cancer	0.000847	0.00115	CcSEcCtD
Roflumilast—Rash—Topotecan—lung cancer	0.000844	0.00115	CcSEcCtD
Roflumilast—Hypersensitivity—Vinorelbine—lung cancer	0.000843	0.00115	CcSEcCtD
Roflumilast—Dermatitis—Topotecan—lung cancer	0.000843	0.00115	CcSEcCtD
Roflumilast—Vomiting—Erlotinib—lung cancer	0.000842	0.00115	CcSEcCtD
Roflumilast—Nervous system disorder—Cisplatin—lung cancer	0.00084	0.00114	CcSEcCtD
Roflumilast—Headache—Topotecan—lung cancer	0.000838	0.00114	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000838	0.00114	CcSEcCtD
Roflumilast—Rash—Erlotinib—lung cancer	0.000835	0.00114	CcSEcCtD
Roflumilast—Dermatitis—Erlotinib—lung cancer	0.000834	0.00113	CcSEcCtD
Roflumilast—Palpitations—Paclitaxel—lung cancer	0.000834	0.00113	CcSEcCtD
Roflumilast—Skin disorder—Cisplatin—lung cancer	0.000832	0.00113	CcSEcCtD
Roflumilast—Insomnia—Gemcitabine—lung cancer	0.000832	0.00113	CcSEcCtD
Roflumilast—Dyspepsia—Irinotecan—lung cancer	0.000831	0.00113	CcSEcCtD
Roflumilast—Immune system disorder—Docetaxel—lung cancer	0.00083	0.00113	CcSEcCtD
Roflumilast—Headache—Erlotinib—lung cancer	0.000829	0.00113	CcSEcCtD
Roflumilast—Mediastinal disorder—Docetaxel—lung cancer	0.000828	0.00113	CcSEcCtD
Roflumilast—Asthenia—Vinorelbine—lung cancer	0.000821	0.00112	CcSEcCtD
Roflumilast—Decreased appetite—Irinotecan—lung cancer	0.00082	0.00112	CcSEcCtD
Roflumilast—Nausea—Vinblastine—lung cancer	0.000818	0.00111	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Irinotecan—lung cancer	0.000815	0.00111	CcSEcCtD
Roflumilast—Fatigue—Irinotecan—lung cancer	0.000814	0.00111	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000813	0.00111	CcSEcCtD
Roflumilast—Discomfort—Etoposide—lung cancer	0.000809	0.0011	CcSEcCtD
Roflumilast—Constipation—Irinotecan—lung cancer	0.000807	0.0011	CcSEcCtD
Roflumilast—Mental disorder—Docetaxel—lung cancer	0.000805	0.0011	CcSEcCtD
Roflumilast—Myalgia—Paclitaxel—lung cancer	0.000803	0.00109	CcSEcCtD
Roflumilast—Anxiety—Paclitaxel—lung cancer	0.0008	0.00109	CcSEcCtD
Roflumilast—Malnutrition—Docetaxel—lung cancer	0.000799	0.00109	CcSEcCtD
Roflumilast—Decreased appetite—Gemcitabine—lung cancer	0.000799	0.00109	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000797	0.00109	CcSEcCtD
Roflumilast—Nausea—Topotecan—lung cancer	0.000795	0.00108	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000794	0.00108	CcSEcCtD
Roflumilast—Discomfort—Paclitaxel—lung cancer	0.000793	0.00108	CcSEcCtD
Roflumilast—Fatigue—Gemcitabine—lung cancer	0.000793	0.00108	CcSEcCtD
Roflumilast—Constipation—Gemcitabine—lung cancer	0.000786	0.00107	CcSEcCtD
Roflumilast—Nausea—Erlotinib—lung cancer	0.000786	0.00107	CcSEcCtD
Roflumilast—Diarrhoea—Vinorelbine—lung cancer	0.000783	0.00107	CcSEcCtD
Roflumilast—Dysgeusia—Docetaxel—lung cancer	0.000783	0.00107	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000781	0.00106	CcSEcCtD
Roflumilast—Infection—Etoposide—lung cancer	0.00078	0.00106	CcSEcCtD
Roflumilast—Feeling abnormal—Irinotecan—lung cancer	0.000778	0.00106	CcSEcCtD
Roflumilast—Back pain—Docetaxel—lung cancer	0.000773	0.00105	CcSEcCtD
Roflumilast—Gastrointestinal pain—Irinotecan—lung cancer	0.000772	0.00105	CcSEcCtD
Roflumilast—Muscle spasms—Docetaxel—lung cancer	0.000769	0.00105	CcSEcCtD
Roflumilast—Infection—Paclitaxel—lung cancer	0.000765	0.00104	CcSEcCtD
Roflumilast—Skin disorder—Etoposide—lung cancer	0.000763	0.00104	CcSEcCtD
Roflumilast—Feeling abnormal—Gemcitabine—lung cancer	0.000758	0.00103	CcSEcCtD
Roflumilast—Dizziness—Vinorelbine—lung cancer	0.000757	0.00103	CcSEcCtD
Roflumilast—Nervous system disorder—Paclitaxel—lung cancer	0.000755	0.00103	CcSEcCtD
Roflumilast—Skin disorder—Paclitaxel—lung cancer	0.000748	0.00102	CcSEcCtD
Roflumilast—Abdominal pain—Irinotecan—lung cancer	0.000746	0.00102	CcSEcCtD
Roflumilast—Decreased appetite—Cisplatin—lung cancer	0.000745	0.00101	CcSEcCtD
Roflumilast—Pneumonia—Methotrexate—lung cancer	0.000742	0.00101	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Cisplatin—lung cancer	0.00074	0.00101	CcSEcCtD
Roflumilast—Infestation NOS—Methotrexate—lung cancer	0.000737	0.001	CcSEcCtD
Roflumilast—Infestation—Methotrexate—lung cancer	0.000737	0.001	CcSEcCtD
Roflumilast—Depression—Methotrexate—lung cancer	0.000735	0.001	CcSEcCtD
Roflumilast—Gastritis—Doxorubicin—lung cancer	0.000733	0.000998	CcSEcCtD
Roflumilast—Vomiting—Vinorelbine—lung cancer	0.000728	0.00099	CcSEcCtD
Roflumilast—Rash—Vinorelbine—lung cancer	0.000722	0.000982	CcSEcCtD
Roflumilast—Dermatitis—Vinorelbine—lung cancer	0.000721	0.000981	CcSEcCtD
Roflumilast—Headache—Vinorelbine—lung cancer	0.000717	0.000976	CcSEcCtD
Roflumilast—Influenza—Doxorubicin—lung cancer	0.000716	0.000975	CcSEcCtD
Roflumilast—Palpitations—Docetaxel—lung cancer	0.000706	0.000962	CcSEcCtD
Roflumilast—Feeling abnormal—Cisplatin—lung cancer	0.000706	0.000961	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000701	0.000955	CcSEcCtD
Roflumilast—Hepatobiliary disease—Methotrexate—lung cancer	0.000697	0.000949	CcSEcCtD
Roflumilast—Insomnia—Paclitaxel—lung cancer	0.000696	0.000948	CcSEcCtD
Roflumilast—Hypersensitivity—Irinotecan—lung cancer	0.000695	0.000946	CcSEcCtD
Roflumilast—Decreased appetite—Etoposide—lung cancer	0.000682	0.000929	CcSEcCtD
Roflumilast—Myalgia—Docetaxel—lung cancer	0.000681	0.000926	CcSEcCtD
Roflumilast—Nausea—Vinorelbine—lung cancer	0.00068	0.000925	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Etoposide—lung cancer	0.000678	0.000922	CcSEcCtD
Roflumilast—Dyspepsia—Paclitaxel—lung cancer	0.000678	0.000922	CcSEcCtD
Roflumilast—Asthenia—Irinotecan—lung cancer	0.000677	0.000922	CcSEcCtD
Roflumilast—Fatigue—Etoposide—lung cancer	0.000677	0.000921	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000676	0.00092	CcSEcCtD
Roflumilast—Constipation—Etoposide—lung cancer	0.000671	0.000914	CcSEcCtD
Roflumilast—Decreased appetite—Paclitaxel—lung cancer	0.000669	0.000911	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000665	0.000904	CcSEcCtD
Roflumilast—Fatigue—Paclitaxel—lung cancer	0.000664	0.000903	CcSEcCtD
Roflumilast—Asthenia—Gemcitabine—lung cancer	0.00066	0.000898	CcSEcCtD
Roflumilast—Constipation—Paclitaxel—lung cancer	0.000658	0.000896	CcSEcCtD
Roflumilast—Infection—Docetaxel—lung cancer	0.000648	0.000882	CcSEcCtD
Roflumilast—Weight decreased—Doxorubicin—lung cancer	0.000648	0.000882	CcSEcCtD
Roflumilast—Feeling abnormal—Etoposide—lung cancer	0.000647	0.000881	CcSEcCtD
Roflumilast—Diarrhoea—Irinotecan—lung cancer	0.000646	0.000879	CcSEcCtD
Roflumilast—Pneumonia—Doxorubicin—lung cancer	0.000642	0.000874	CcSEcCtD
Roflumilast—Gastrointestinal pain—Etoposide—lung cancer	0.000642	0.000874	CcSEcCtD
Roflumilast—Nervous system disorder—Docetaxel—lung cancer	0.00064	0.000871	CcSEcCtD
Roflumilast—Infestation NOS—Doxorubicin—lung cancer	0.000638	0.000869	CcSEcCtD
Roflumilast—Infestation—Doxorubicin—lung cancer	0.000638	0.000869	CcSEcCtD
Roflumilast—Feeling abnormal—Paclitaxel—lung cancer	0.000634	0.000863	CcSEcCtD
Roflumilast—Skin disorder—Docetaxel—lung cancer	0.000634	0.000863	CcSEcCtD
Roflumilast—Hypersensitivity—Cisplatin—lung cancer	0.000631	0.000859	CcSEcCtD
Roflumilast—Gastrointestinal pain—Paclitaxel—lung cancer	0.000629	0.000857	CcSEcCtD
Roflumilast—Diarrhoea—Gemcitabine—lung cancer	0.000629	0.000856	CcSEcCtD
Roflumilast—Dizziness—Irinotecan—lung cancer	0.000624	0.000849	CcSEcCtD
Roflumilast—Urticaria—Etoposide—lung cancer	0.000624	0.000849	CcSEcCtD
Roflumilast—Abdominal pain—Etoposide—lung cancer	0.000621	0.000845	CcSEcCtD
Roflumilast—Urinary tract infection—Doxorubicin—lung cancer	0.000621	0.000845	CcSEcCtD
Roflumilast—Asthenia—Cisplatin—lung cancer	0.000615	0.000837	CcSEcCtD
Roflumilast—Cardiac disorder—Methotrexate—lung cancer	0.000614	0.000836	CcSEcCtD
Roflumilast—Urticaria—Paclitaxel—lung cancer	0.000612	0.000832	CcSEcCtD
Roflumilast—PDE4B—lymph node—lung cancer	0.00061	0.0348	CbGeAlD
Roflumilast—Abdominal pain—Paclitaxel—lung cancer	0.000609	0.000828	CcSEcCtD
Roflumilast—Hepatobiliary disease—Doxorubicin—lung cancer	0.000604	0.000822	CcSEcCtD
Roflumilast—Vomiting—Irinotecan—lung cancer	0.0006	0.000817	CcSEcCtD
Roflumilast—Sinusitis—Doxorubicin—lung cancer	0.000599	0.000815	CcSEcCtD
Roflumilast—Immune system disorder—Methotrexate—lung cancer	0.000598	0.000814	CcSEcCtD
Roflumilast—Mediastinal disorder—Methotrexate—lung cancer	0.000597	0.000812	CcSEcCtD
Roflumilast—Rash—Irinotecan—lung cancer	0.000595	0.00081	CcSEcCtD
Roflumilast—Dermatitis—Irinotecan—lung cancer	0.000595	0.000809	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000594	0.000809	CcSEcCtD
Roflumilast—Headache—Irinotecan—lung cancer	0.000591	0.000805	CcSEcCtD
Roflumilast—Insomnia—Docetaxel—lung cancer	0.00059	0.000803	CcSEcCtD
Roflumilast—Diarrhoea—Cisplatin—lung cancer	0.000586	0.000798	CcSEcCtD
Roflumilast—Vomiting—Gemcitabine—lung cancer	0.000585	0.000796	CcSEcCtD
Roflumilast—Mental disorder—Methotrexate—lung cancer	0.00058	0.000789	CcSEcCtD
Roflumilast—Rash—Gemcitabine—lung cancer	0.00058	0.000789	CcSEcCtD
Roflumilast—Dermatitis—Gemcitabine—lung cancer	0.000579	0.000788	CcSEcCtD
Roflumilast—Hypersensitivity—Etoposide—lung cancer	0.000578	0.000787	CcSEcCtD
Roflumilast—Malnutrition—Methotrexate—lung cancer	0.000576	0.000784	CcSEcCtD
Roflumilast—Headache—Gemcitabine—lung cancer	0.000576	0.000784	CcSEcCtD
Roflumilast—Rhinitis—Doxorubicin—lung cancer	0.000575	0.000782	CcSEcCtD
Roflumilast—Dyspepsia—Docetaxel—lung cancer	0.000574	0.000782	CcSEcCtD
Roflumilast—Decreased appetite—Docetaxel—lung cancer	0.000567	0.000772	CcSEcCtD
Roflumilast—Hypersensitivity—Paclitaxel—lung cancer	0.000567	0.000772	CcSEcCtD
Roflumilast—Dysgeusia—Methotrexate—lung cancer	0.000564	0.000768	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Docetaxel—lung cancer	0.000563	0.000767	CcSEcCtD
Roflumilast—Asthenia—Etoposide—lung cancer	0.000563	0.000767	CcSEcCtD
Roflumilast—Connective tissue disorder—Doxorubicin—lung cancer	0.000563	0.000767	CcSEcCtD
Roflumilast—Fatigue—Docetaxel—lung cancer	0.000563	0.000766	CcSEcCtD
Roflumilast—Nausea—Irinotecan—lung cancer	0.000561	0.000763	CcSEcCtD
Roflumilast—Constipation—Docetaxel—lung cancer	0.000558	0.000759	CcSEcCtD
Roflumilast—Back pain—Methotrexate—lung cancer	0.000557	0.000759	CcSEcCtD
Roflumilast—Asthenia—Paclitaxel—lung cancer	0.000552	0.000752	CcSEcCtD
Roflumilast—Nausea—Gemcitabine—lung cancer	0.000546	0.000743	CcSEcCtD
Roflumilast—Vomiting—Cisplatin—lung cancer	0.000545	0.000742	CcSEcCtD
Roflumilast—Rash—Cisplatin—lung cancer	0.00054	0.000735	CcSEcCtD
Roflumilast—Dermatitis—Cisplatin—lung cancer	0.00054	0.000735	CcSEcCtD
Roflumilast—Feeling abnormal—Docetaxel—lung cancer	0.000538	0.000732	CcSEcCtD
Roflumilast—Diarrhoea—Etoposide—lung cancer	0.000537	0.000731	CcSEcCtD
Roflumilast—Ill-defined disorder—Methotrexate—lung cancer	0.000535	0.000728	CcSEcCtD
Roflumilast—Gastrointestinal pain—Docetaxel—lung cancer	0.000534	0.000726	CcSEcCtD
Roflumilast—Cardiac disorder—Doxorubicin—lung cancer	0.000532	0.000724	CcSEcCtD
Roflumilast—Diarrhoea—Paclitaxel—lung cancer	0.000527	0.000717	CcSEcCtD
Roflumilast—Malaise—Methotrexate—lung cancer	0.00052	0.000707	CcSEcCtD
Roflumilast—Dizziness—Etoposide—lung cancer	0.000519	0.000707	CcSEcCtD
Roflumilast—Immune system disorder—Doxorubicin—lung cancer	0.000518	0.000705	CcSEcCtD
Roflumilast—Vertigo—Methotrexate—lung cancer	0.000518	0.000705	CcSEcCtD
Roflumilast—Mediastinal disorder—Doxorubicin—lung cancer	0.000517	0.000703	CcSEcCtD
Roflumilast—Abdominal pain—Docetaxel—lung cancer	0.000516	0.000702	CcSEcCtD
Roflumilast—Dizziness—Paclitaxel—lung cancer	0.000509	0.000693	CcSEcCtD
Roflumilast—Nausea—Cisplatin—lung cancer	0.000509	0.000693	CcSEcCtD
Roflumilast—Mental disorder—Doxorubicin—lung cancer	0.000502	0.000683	CcSEcCtD
Roflumilast—Vomiting—Etoposide—lung cancer	0.000499	0.000679	CcSEcCtD
Roflumilast—Malnutrition—Doxorubicin—lung cancer	0.000499	0.000679	CcSEcCtD
Roflumilast—Rash—Etoposide—lung cancer	0.000495	0.000674	CcSEcCtD
Roflumilast—Dermatitis—Etoposide—lung cancer	0.000495	0.000673	CcSEcCtD
Roflumilast—Headache—Etoposide—lung cancer	0.000492	0.000669	CcSEcCtD
Roflumilast—Myalgia—Methotrexate—lung cancer	0.000491	0.000668	CcSEcCtD
Roflumilast—Tension—Doxorubicin—lung cancer	0.00049	0.000666	CcSEcCtD
Roflumilast—Vomiting—Paclitaxel—lung cancer	0.000489	0.000666	CcSEcCtD
Roflumilast—Dysgeusia—Doxorubicin—lung cancer	0.000489	0.000665	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000487	0.000663	CcSEcCtD
Roflumilast—Rash—Paclitaxel—lung cancer	0.000485	0.000661	CcSEcCtD
Roflumilast—Dermatitis—Paclitaxel—lung cancer	0.000485	0.00066	CcSEcCtD
Roflumilast—Discomfort—Methotrexate—lung cancer	0.000485	0.00066	CcSEcCtD
Roflumilast—Nervousness—Doxorubicin—lung cancer	0.000485	0.00066	CcSEcCtD
Roflumilast—Back pain—Doxorubicin—lung cancer	0.000483	0.000657	CcSEcCtD
Roflumilast—Headache—Paclitaxel—lung cancer	0.000482	0.000656	CcSEcCtD
Roflumilast—Hypersensitivity—Docetaxel—lung cancer	0.000481	0.000654	CcSEcCtD
Roflumilast—Muscle spasms—Doxorubicin—lung cancer	0.00048	0.000653	CcSEcCtD
Roflumilast—Asthenia—Docetaxel—lung cancer	0.000468	0.000637	CcSEcCtD
Roflumilast—Infection—Methotrexate—lung cancer	0.000467	0.000636	CcSEcCtD
Roflumilast—Nausea—Etoposide—lung cancer	0.000466	0.000635	CcSEcCtD
Roflumilast—Ill-defined disorder—Doxorubicin—lung cancer	0.000463	0.00063	CcSEcCtD
Roflumilast—Nervous system disorder—Methotrexate—lung cancer	0.000461	0.000628	CcSEcCtD
Roflumilast—Nausea—Paclitaxel—lung cancer	0.000457	0.000622	CcSEcCtD
Roflumilast—Skin disorder—Methotrexate—lung cancer	0.000457	0.000622	CcSEcCtD
Roflumilast—Malaise—Doxorubicin—lung cancer	0.00045	0.000612	CcSEcCtD
Roflumilast—Vertigo—Doxorubicin—lung cancer	0.000448	0.00061	CcSEcCtD
Roflumilast—Diarrhoea—Docetaxel—lung cancer	0.000446	0.000608	CcSEcCtD
Roflumilast—Palpitations—Doxorubicin—lung cancer	0.000441	0.0006	CcSEcCtD
Roflumilast—Dizziness—Docetaxel—lung cancer	0.000431	0.000587	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000428	0.000583	CcSEcCtD
Roflumilast—Insomnia—Methotrexate—lung cancer	0.000425	0.000579	CcSEcCtD
Roflumilast—Myalgia—Doxorubicin—lung cancer	0.000425	0.000578	CcSEcCtD
Roflumilast—Anxiety—Doxorubicin—lung cancer	0.000423	0.000576	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000422	0.000574	CcSEcCtD
Roflumilast—Discomfort—Doxorubicin—lung cancer	0.00042	0.000571	CcSEcCtD
Roflumilast—Vomiting—Docetaxel—lung cancer	0.000415	0.000565	CcSEcCtD
Roflumilast—Dyspepsia—Methotrexate—lung cancer	0.000414	0.000563	CcSEcCtD
Roflumilast—Rash—Docetaxel—lung cancer	0.000411	0.00056	CcSEcCtD
Roflumilast—Dermatitis—Docetaxel—lung cancer	0.000411	0.000559	CcSEcCtD
Roflumilast—Decreased appetite—Methotrexate—lung cancer	0.000409	0.000556	CcSEcCtD
Roflumilast—Headache—Docetaxel—lung cancer	0.000409	0.000556	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Methotrexate—lung cancer	0.000406	0.000553	CcSEcCtD
Roflumilast—Fatigue—Methotrexate—lung cancer	0.000405	0.000552	CcSEcCtD
Roflumilast—Infection—Doxorubicin—lung cancer	0.000405	0.000551	CcSEcCtD
Roflumilast—Nervous system disorder—Doxorubicin—lung cancer	0.000399	0.000543	CcSEcCtD
Roflumilast—Skin disorder—Doxorubicin—lung cancer	0.000396	0.000538	CcSEcCtD
Roflumilast—Nausea—Docetaxel—lung cancer	0.000388	0.000527	CcSEcCtD
Roflumilast—Feeling abnormal—Methotrexate—lung cancer	0.000388	0.000527	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methotrexate—lung cancer	0.000385	0.000523	CcSEcCtD
Roflumilast—Urticaria—Methotrexate—lung cancer	0.000374	0.000508	CcSEcCtD
Roflumilast—Abdominal pain—Methotrexate—lung cancer	0.000372	0.000506	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000371	0.000505	CcSEcCtD
Roflumilast—Insomnia—Doxorubicin—lung cancer	0.000368	0.000501	CcSEcCtD
Roflumilast—Dyspepsia—Doxorubicin—lung cancer	0.000358	0.000488	CcSEcCtD
Roflumilast—Decreased appetite—Doxorubicin—lung cancer	0.000354	0.000482	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000352	0.000478	CcSEcCtD
Roflumilast—Fatigue—Doxorubicin—lung cancer	0.000351	0.000478	CcSEcCtD
Roflumilast—Constipation—Doxorubicin—lung cancer	0.000348	0.000474	CcSEcCtD
Roflumilast—Hypersensitivity—Methotrexate—lung cancer	0.000346	0.000472	CcSEcCtD
Roflumilast—Asthenia—Methotrexate—lung cancer	0.000337	0.000459	CcSEcCtD
Roflumilast—Feeling abnormal—Doxorubicin—lung cancer	0.000336	0.000457	CcSEcCtD
Roflumilast—Gastrointestinal pain—Doxorubicin—lung cancer	0.000333	0.000453	CcSEcCtD
Roflumilast—Urticaria—Doxorubicin—lung cancer	0.000323	0.00044	CcSEcCtD
Roflumilast—Abdominal pain—Doxorubicin—lung cancer	0.000322	0.000438	CcSEcCtD
Roflumilast—Diarrhoea—Methotrexate—lung cancer	0.000322	0.000438	CcSEcCtD
Roflumilast—Dizziness—Methotrexate—lung cancer	0.000311	0.000423	CcSEcCtD
Roflumilast—Hypersensitivity—Doxorubicin—lung cancer	0.0003	0.000408	CcSEcCtD
Roflumilast—Vomiting—Methotrexate—lung cancer	0.000299	0.000407	CcSEcCtD
Roflumilast—Rash—Methotrexate—lung cancer	0.000297	0.000404	CcSEcCtD
Roflumilast—Dermatitis—Methotrexate—lung cancer	0.000296	0.000403	CcSEcCtD
Roflumilast—Headache—Methotrexate—lung cancer	0.000295	0.000401	CcSEcCtD
Roflumilast—Asthenia—Doxorubicin—lung cancer	0.000292	0.000398	CcSEcCtD
Roflumilast—Nausea—Methotrexate—lung cancer	0.000279	0.00038	CcSEcCtD
Roflumilast—Diarrhoea—Doxorubicin—lung cancer	0.000279	0.000379	CcSEcCtD
Roflumilast—Dizziness—Doxorubicin—lung cancer	0.000269	0.000366	CcSEcCtD
Roflumilast—Vomiting—Doxorubicin—lung cancer	0.000259	0.000352	CcSEcCtD
Roflumilast—Rash—Doxorubicin—lung cancer	0.000257	0.000349	CcSEcCtD
Roflumilast—Dermatitis—Doxorubicin—lung cancer	0.000257	0.000349	CcSEcCtD
Roflumilast—Headache—Doxorubicin—lung cancer	0.000255	0.000347	CcSEcCtD
Roflumilast—Nausea—Doxorubicin—lung cancer	0.000242	0.000329	CcSEcCtD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CB—lung cancer	0.000133	0.000536	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—MAP2K1—lung cancer	0.000133	0.000535	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ERBB3—lung cancer	0.000132	0.000534	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—POMC—lung cancer	0.000132	0.000533	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CD—lung cancer	0.000132	0.000532	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STK11—lung cancer	0.00013	0.000524	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6R—lung cancer	0.000129	0.00052	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1R—lung cancer	0.000128	0.000518	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CXCL8—lung cancer	0.000128	0.000515	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL2—lung cancer	0.000127	0.000514	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AVP—lung cancer	0.000127	0.000512	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TERT—lung cancer	0.000127	0.000512	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CB—lung cancer	0.000126	0.00051	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HES1—lung cancer	0.000126	0.000509	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FOXO3—lung cancer	0.000125	0.000505	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—RAF1—lung cancer	0.000124	0.000499	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGFR1—lung cancer	0.000123	0.000497	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—MAP2K1—lung cancer	0.000123	0.000495	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1R—lung cancer	0.000122	0.000493	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—IL2—lung cancer	0.000122	0.000492	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CD—lung cancer	0.000122	0.000492	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCL8—lung cancer	0.000121	0.000491	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HIF1A—lung cancer	0.000121	0.00049	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CB—lung cancer	0.000121	0.000487	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HES1—lung cancer	0.00012	0.000484	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—RAF1—lung cancer	0.000118	0.000475	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AVP—lung cancer	0.000117	0.000474	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOA1—lung cancer	0.000117	0.000472	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CB—lung cancer	0.000117	0.000472	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—IL2—lung cancer	0.000116	0.000469	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KDR—lung cancer	0.000116	0.000468	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCL8—lung cancer	0.000116	0.000468	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ERBB3—lung cancer	0.000115	0.000465	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CB—lung cancer	0.000115	0.000464	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1R—lung cancer	0.000113	0.000456	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCL8—lung cancer	0.000112	0.000454	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HES1—lung cancer	0.000111	0.000448	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL2—lung cancer	0.000111	0.000447	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TERT—lung cancer	0.00011	0.000446	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCL8—lung cancer	0.00011	0.000445	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ERBB3—lung cancer	0.00011	0.000443	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—RAF1—lung cancer	0.000109	0.000439	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—IL2—lung cancer	0.000107	0.000434	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGFR1—lung cancer	0.000107	0.000433	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CG—lung cancer	0.000107	0.000431	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APC—lung cancer	0.000107	0.000431	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KIT—lung cancer	0.000107	0.000431	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—NRAS—lung cancer	0.000107	0.000431	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CB—lung cancer	0.000106	0.000429	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EGF—lung cancer	0.000106	0.000426	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HIF1A—lung cancer	0.000106	0.000426	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL2—lung cancer	0.000105	0.000426	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TERT—lung cancer	0.000105	0.000424	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—MAPK3—lung cancer	0.000102	0.000413	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCL8—lung cancer	0.000102	0.000412	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGFR1—lung cancer	0.000102	0.000412	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOA1—lung cancer	0.000102	0.000411	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—lung cancer	0.000102	0.000411	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ERBB3—lung cancer	0.000101	0.000409	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KDR—lung cancer	0.000101	0.000408	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HIF1A—lung cancer	0.0001	0.000406	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—BRAF—lung cancer	0.0001	0.000405	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6R—lung cancer	9.92e-05	0.0004	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CREBBP—lung cancer	9.9e-05	0.0004	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL2—lung cancer	9.76e-05	0.000394	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—EGFR—lung cancer	9.73e-05	0.000393	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TERT—lung cancer	9.72e-05	0.000392	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOA1—lung cancer	9.7e-05	0.000391	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KDR—lung cancer	9.61e-05	0.000388	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAP2K1—lung cancer	9.45e-05	0.000382	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGFR1—lung cancer	9.44e-05	0.000381	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CD—lung cancer	9.39e-05	0.000379	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CA—lung cancer	9.3e-05	0.000376	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APC—lung cancer	9.3e-05	0.000375	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CG—lung cancer	9.3e-05	0.000375	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KIT—lung cancer	9.3e-05	0.000375	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—NRAS—lung cancer	9.3e-05	0.000375	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HIF1A—lung cancer	9.3e-05	0.000375	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—KRAS—lung cancer	9.19e-05	0.000371	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EGF—lung cancer	9.19e-05	0.000371	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOA1—lung cancer	8.97e-05	0.000362	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—MAPK3—lung cancer	8.91e-05	0.00036	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KDR—lung cancer	8.89e-05	0.000359	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—lung cancer	8.85e-05	0.000357	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CG—lung cancer	8.85e-05	0.000357	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KIT—lung cancer	8.85e-05	0.000357	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APC—lung cancer	8.85e-05	0.000357	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—NRAS—lung cancer	8.85e-05	0.000357	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EGF—lung cancer	8.75e-05	0.000353	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—BRAF—lung cancer	8.74e-05	0.000353	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6R—lung cancer	8.63e-05	0.000349	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CREBBP—lung cancer	8.62e-05	0.000348	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—MAPK3—lung cancer	8.48e-05	0.000342	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—EGFR—lung cancer	8.47e-05	0.000342	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CA—lung cancer	8.45e-05	0.000341	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—lung cancer	8.43e-05	0.00034	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MDM2—lung cancer	8.41e-05	0.00034	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RAF1—lung cancer	8.38e-05	0.000338	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—BRAF—lung cancer	8.32e-05	0.000336	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ERBB2—lung cancer	8.29e-05	0.000335	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAP2K1—lung cancer	8.23e-05	0.000332	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6R—lung cancer	8.22e-05	0.000332	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CREBBP—lung cancer	8.21e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APC—lung cancer	8.19e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KIT—lung cancer	8.19e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CG—lung cancer	8.19e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—NRAS—lung cancer	8.19e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CB—lung cancer	8.19e-05	0.00033	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MTOR—lung cancer	8.19e-05	0.00033	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CD—lung cancer	8.17e-05	0.00033	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CA—lung cancer	8.1e-05	0.000327	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EGF—lung cancer	8.1e-05	0.000327	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—EGFR—lung cancer	8.06e-05	0.000326	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—KRAS—lung cancer	8e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL8—lung cancer	7.87e-05	0.000318	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—MAPK3—lung cancer	7.84e-05	0.000317	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAP2K1—lung cancer	7.83e-05	0.000316	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRAS—lung cancer	7.81e-05	0.000316	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—lung cancer	7.8e-05	0.000315	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CD—lung cancer	7.78e-05	0.000314	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CA—lung cancer	7.71e-05	0.000311	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—BRAF—lung cancer	7.7e-05	0.000311	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—KRAS—lung cancer	7.62e-05	0.000308	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6R—lung cancer	7.6e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—lung cancer	7.6e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CREBBP—lung cancer	7.59e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—lung cancer	7.53e-05	0.000304	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL2—lung cancer	7.52e-05	0.000303	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—lung cancer	7.48e-05	0.000302	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—EGFR—lung cancer	7.46e-05	0.000301	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CA—lung cancer	7.35e-05	0.000297	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCND1—lung cancer	7.33e-05	0.000296	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MDM2—lung cancer	7.32e-05	0.000296	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JUN—lung cancer	7.31e-05	0.000295	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RAF1—lung cancer	7.3e-05	0.000295	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAP2K1—lung cancer	7.25e-05	0.000293	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ERBB2—lung cancer	7.22e-05	0.000292	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CD—lung cancer	7.2e-05	0.000291	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CA—lung cancer	7.13e-05	0.000288	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MTOR—lung cancer	7.13e-05	0.000288	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CB—lung cancer	7.13e-05	0.000288	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—lung cancer	7.11e-05	0.000287	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN1A—lung cancer	7.09e-05	0.000286	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTEN—lung cancer	7.07e-05	0.000286	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—KRAS—lung cancer	7.05e-05	0.000285	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CA—lung cancer	7e-05	0.000283	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MDM2—lung cancer	6.97e-05	0.000281	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RAF1—lung cancer	6.95e-05	0.00028	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—lung cancer	6.9e-05	0.000279	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ERBB2—lung cancer	6.87e-05	0.000277	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL8—lung cancer	6.85e-05	0.000276	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRAS—lung cancer	6.8e-05	0.000275	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MTOR—lung cancer	6.78e-05	0.000274	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CB—lung cancer	6.78e-05	0.000274	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EP300—lung cancer	6.75e-05	0.000272	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—lung cancer	6.61e-05	0.000267	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SRC—lung cancer	6.56e-05	0.000265	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—lung cancer	6.55e-05	0.000265	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL2—lung cancer	6.54e-05	0.000264	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL8—lung cancer	6.52e-05	0.000263	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—lung cancer	6.51e-05	0.000263	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CA—lung cancer	6.48e-05	0.000261	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRAS—lung cancer	6.48e-05	0.000261	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MDM2—lung cancer	6.45e-05	0.00026	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RAF1—lung cancer	6.43e-05	0.00026	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—lung cancer	6.39e-05	0.000258	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCND1—lung cancer	6.38e-05	0.000258	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JUN—lung cancer	6.37e-05	0.000257	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ERBB2—lung cancer	6.36e-05	0.000257	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STAT3—lung cancer	6.33e-05	0.000255	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NRAS—lung cancer	6.31e-05	0.000255	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—lung cancer	6.3e-05	0.000254	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MTOR—lung cancer	6.28e-05	0.000253	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CB—lung cancer	6.28e-05	0.000253	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—lung cancer	6.24e-05	0.000252	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL2—lung cancer	6.23e-05	0.000251	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—lung cancer	6.2e-05	0.00025	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—lung cancer	6.19e-05	0.00025	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN1A—lung cancer	6.17e-05	0.000249	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTEN—lung cancer	6.16e-05	0.000249	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCND1—lung cancer	6.07e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JUN—lung cancer	6.06e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK3—lung cancer	6.04e-05	0.000244	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL8—lung cancer	6.03e-05	0.000243	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—lung cancer	6.01e-05	0.000243	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRAS—lung cancer	5.99e-05	0.000242	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—lung cancer	5.9e-05	0.000238	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—lung cancer	5.88e-05	0.000237	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN1A—lung cancer	5.87e-05	0.000237	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EP300—lung cancer	5.87e-05	0.000237	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTEN—lung cancer	5.86e-05	0.000237	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—lung cancer	5.83e-05	0.000235	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—lung cancer	5.77e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL2—lung cancer	5.76e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EGFR—lung cancer	5.75e-05	0.000232	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—lung cancer	5.73e-05	0.000232	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—lung cancer	5.72e-05	0.000231	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SRC—lung cancer	5.71e-05	0.000231	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCND1—lung cancer	5.62e-05	0.000227	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JUN—lung cancer	5.61e-05	0.000226	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EP300—lung cancer	5.59e-05	0.000226	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—lung cancer	5.56e-05	0.000225	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STAT3—lung cancer	5.51e-05	0.000222	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NRAS—lung cancer	5.49e-05	0.000222	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—lung cancer	5.45e-05	0.00022	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN1A—lung cancer	5.44e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SRC—lung cancer	5.44e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KRAS—lung cancer	5.43e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTEN—lung cancer	5.42e-05	0.000219	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—lung cancer	5.29e-05	0.000214	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—lung cancer	5.29e-05	0.000214	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK3—lung cancer	5.26e-05	0.000212	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STAT3—lung cancer	5.24e-05	0.000212	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NRAS—lung cancer	5.23e-05	0.000211	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EP300—lung cancer	5.17e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—lung cancer	5.12e-05	0.000207	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SRC—lung cancer	5.03e-05	0.000203	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK3—lung cancer	5.01e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EGFR—lung cancer	5e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CA—lung cancer	4.99e-05	0.000201	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—lung cancer	4.9e-05	0.000198	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—lung cancer	4.87e-05	0.000197	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STAT3—lung cancer	4.85e-05	0.000196	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NRAS—lung cancer	4.84e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—lung cancer	4.83e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EGFR—lung cancer	4.76e-05	0.000192	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KRAS—lung cancer	4.73e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK3—lung cancer	4.63e-05	0.000187	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRAS—lung cancer	4.62e-05	0.000186	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—lung cancer	4.51e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KRAS—lung cancer	4.5e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—lung cancer	4.42e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EGFR—lung cancer	4.41e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CA—lung cancer	4.34e-05	0.000175	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—lung cancer	4.2e-05	0.00017	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KRAS—lung cancer	4.16e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CA—lung cancer	4.13e-05	0.000167	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—lung cancer	4.08e-05	0.000165	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRAS—lung cancer	4.02e-05	0.000162	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—lung cancer	4e-05	0.000161	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—lung cancer	3.85e-05	0.000155	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CA—lung cancer	3.83e-05	0.000154	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRAS—lung cancer	3.83e-05	0.000154	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—lung cancer	3.7e-05	0.000149	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—lung cancer	3.66e-05	0.000148	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—lung cancer	3.55e-05	0.000143	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRAS—lung cancer	3.54e-05	0.000143	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—lung cancer	3.39e-05	0.000137	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—lung cancer	3.38e-05	0.000136	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—lung cancer	3.13e-05	0.000126	CbGpPWpGaD
